Hiltunen AE, Kangas SM, Gondane A, Koivisto H, Salokas K, Heikkinen A, Salo MH, Röning T, Tallgren A, Glumoff V, Denis MC, Karagianni N, Myllyharju J, Varjosalo M, Tanila H, Itkonen HM, Rämet M, Uusimaa J, Hinttala R. Altered behaviour and immune response in mice with NHLRC2 p.Asp148Tyr variant.Brain Behav Immun Health. PMID: 40510178.
Urbanucci A*, Barfeld SJ, Kytölä V, Itkonen HM, Coleman IM, Vodák D, Sjöblom L, Sheng X, Tolonen T, Minner S, Burdelski C, Kivinummi KK, Kohvakka A, Kregel S, Takhar M, Alshalalfa M, Davicioni E, Erho N, Lloyd P, Karnes RJ, Ross AE, Schaeffer EM, Vander Griend DJ, Knapp S, Corey E, Feng FY, Nelson PS, Saatcioglu F, Knudsen KE, Tammela TLJ, Sauter G, Schlomm T, Nykter M, Visakorpi T, Mills IG*. Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer.Cell Reports 2017. PMID: 28591577.
Itkonen HM*, Brown M, Urbanucci A, Tredwell G, Ho Lau C, Barfeld S, Hart C, Guldvik IJ, Takhar M, Heemers HV, Erho N, Bloch K, Davicioni E, Derua R, Waelkens E, Mohler JL, Clarke N, Swinnen JV, Keun HC, Rekvig OP, Mills IG*. Lipid degradation promotes prostate cancer cell survival. Oncotarget 2017. PMID: 28415728.